ATE176470T1 - Xanthinderivate - Google Patents

Xanthinderivate

Info

Publication number
ATE176470T1
ATE176470T1 AT91917824T AT91917824T ATE176470T1 AT E176470 T1 ATE176470 T1 AT E176470T1 AT 91917824 T AT91917824 T AT 91917824T AT 91917824 T AT91917824 T AT 91917824T AT E176470 T1 ATE176470 T1 AT E176470T1
Authority
AT
Austria
Prior art keywords
represents hydrogen
different
same
xanthine derivatives
formula
Prior art date
Application number
AT91917824T
Other languages
English (en)
Inventor
Fumio Suzuki
Junichi Shimada
Akio Ishii
Hiromi Nonaka
Nobuo Kosaka
Shunji Hita Ichikawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE176470T1 publication Critical patent/ATE176470T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
AT91917824T 1990-10-18 1991-10-17 Xanthinderivate ATE176470T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28017190 1990-10-18

Publications (1)

Publication Number Publication Date
ATE176470T1 true ATE176470T1 (de) 1999-02-15

Family

ID=17621294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917824T ATE176470T1 (de) 1990-10-18 1991-10-17 Xanthinderivate

Country Status (6)

Country Link
EP (1) EP0559893B1 (de)
AT (1) ATE176470T1 (de)
CA (1) CA2094270C (de)
DE (1) DE69130869T2 (de)
ES (1) ES2130138T3 (de)
WO (1) WO1992006976A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
ATE216584T1 (de) * 1992-07-08 2002-05-15 Kyowa Hakko Kogyo Kk Xanthine-derivate als antidepressiva
TW252044B (de) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
CA2112031A1 (en) * 1992-12-24 1994-06-25 Fumio Suzuki Xanthine derivatives
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
US5703085A (en) * 1994-02-23 1997-12-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
DE69834500T2 (de) 1997-09-05 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. Xanthinderivative zur behandlung von hirnischämie
CA2315736A1 (en) 1998-01-05 1999-07-15 Eisai Co., Ltd. Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus
EP1234576B1 (de) * 1999-10-29 2006-03-08 Kyowa Hakko Kogyo Co., Ltd. Arzneimittel gegen essstörungen
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
JP4376630B2 (ja) 2002-01-28 2009-12-02 協和発酵キリン株式会社 運動障害治療剤
US20060122198A1 (en) * 2003-06-27 2006-06-08 Kyowa Hakko Kogyo Co., Ltd. Antiepileptic agent
EP1709967A4 (de) 2004-01-28 2010-09-15 Kyowa Hakko Kirin Co Ltd Mittel zur behandlung von migräne
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
JP2010511628A (ja) * 2006-12-01 2010-04-15 ギリアード・パロ・アルト・インコーポレイテッド Ａ２ａアデノシン受容体アンタゴニスト
MX2009006346A (es) * 2006-12-22 2010-03-03 Sanol Arznei Schwarz Gmbh Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos.
RU2477726C1 (ru) * 2011-10-18 2013-03-20 Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") Замещенные феноксиуксусные кислоты, их эфиры и амиды, включающие 2,6-диоксо-2,3,6,7-тетрагидро-1н-пурин-8-иловый фрагмент, - антагонисты аденозинового a2a рецептора и их применение
CN110981876B (zh) * 2018-12-21 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2028235C (en) * 1989-10-20 1997-01-21 Fumio Suzuki Condensed purine derivatives

Also Published As

Publication number Publication date
DE69130869D1 (en) 1999-03-18
ES2130138T3 (es) 1999-07-01
DE69130869T2 (de) 1999-06-10
EP0559893B1 (de) 1999-02-03
CA2094270A1 (en) 1992-04-19
EP0559893A1 (de) 1993-09-15
CA2094270C (en) 1997-01-21
WO1992006976A1 (fr) 1992-04-30
EP0559893A4 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
ATE176470T1 (de) Xanthinderivate
DK0784974T3 (da) Fremstilling af xanthinderivater i fast dispersion
DE69628804T2 (de) Substitutierte heterozyclische Derivate als CRF Antagonisten
DE69839735D1 (de) Pyrimidin-5-carboxamid-derivate
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
DE69809959T2 (de) Neue taxanderivate
DE69027235D1 (de) Xanthinderivate
EP0358190A3 (de) Polysiloxane mit sterisch gehinderten Gruppen
HUT47789A (en) Compositions containing n-/dihalogeno-acetyl/-oxazolidine derivatives as antidotum substituted with heterocyclic group at the 5-position
ATE237612T1 (de) Benzofuranderivate
FI930429A (fi) Nya 1,4-dihyropyridinderivat
DE69731556D1 (de) Fettemulsion, die ein xanthinderivat enthält
DE3264253D1 (de) Pyridine derivatives as histamine h2 antagonists
EP0579836A4 (de)
WO1997020814A1 (fr) Derives du propenone
FI913893A (fi) Tricykliska heterocykliska derivat.
DE69121413D1 (de) Pyridyl-pyrimidinderivate als fungizide verbindungen
FI940607A0 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
NO932258D0 (no) Heterocykliske, skadedyrdrepende forbindelser
ZA916468B (en) Substituted heterobicyclic imidazole derivatives as paf antagonists
ATE268769T1 (de) Pyrimidinderivate mit antitumor-wirkung
NO910618L (no) Heterocykliske forbindelser.
LT2339B (lt) 5-(nq -nitro-na-tret.-butiloksikarbonil)arginilaminonaftalin-1-sulfamidai kaip tarpiniai produktai 5-arginil-1-aminonaftalinsulfamidams gauti
ITMI912233A1 (it) Derivati dell'1, 2, 4, -triazolo farmacologicamente attivi
ES1015051Y (es) Descensor de pesos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties